| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Centessa Pharmaceuticals plc | Chief Accounting Officer | Ordinary Shares | 11,000 | $275,110 | $25.01 | 02 Feb 2026 | Direct |
| Centessa Pharmaceuticals plc | Chief Accounting Officer | Share Option (right to buy) | 42,000 | 02 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CNTA | Centessa Pharmaceuticals plc | 02 Feb 2026 | 2 | $0 | 4 | Chief Accounting Officer | 03 Feb 2026, 19:01 |
| CNTA | Centessa Pharmaceuticals plc | 02 Jun 2025 | 1 | $0 | 4 | Chief Accounting Officer | 03 Jun 2025, 16:26 |
| CNTA | Centessa Pharmaceuticals plc | 27 May 2025 | 0 | $0 | 3 | Chief Accounting Officer | 03 Jun 2025, 16:24 |